Despite stories of questionable use of health care data, my concern with GOOGL is technical: We need a retest of $1,250 to $1,275 before we can move significantly higher.
Let's check out the charts of this medical technologies company.
Let others wait and see if someone comes in with a better offer than Alphabet's bid for Fitbit; this value investor is taking his profit and leaving the table.
Let's review the charts and indicators of NVCR.
The maker of wearable fitness devices has seen its stock sprint higher on the buyout news after languishing this summer near multi-year lows.
After correction, the medical device maker could see longer-term gains to the $150-$161 area.
If you are not already long EW or just want to add to longs you should use any minor intraday dip today or tomorrow to buy.
Let's review the charts and indicators of ISRG.
As the robotics sector of medicine begins to mature, ISRG finds itself as one of the old guard.
Sellers of the drugstore chain's stock have been aggressive for months and the overall technical picture is weak.